![Emile Loria](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emile Loria
Founder at
Dendrogenix SA
Net worth: 12 M $ as of 2026-05-30
Profile
Emile Loria is the founder of Ms Medical Synergy SA, founded in 1986.
Dr. Loria was the founder of Orphan Synergy Europe-Pharma SA, founded in 2004, and held the title of Chairman.
Dr. Loria was the founder of OSE Immunotherapeutics SA, founded in 2012, and held the title of Chairman from 2012 to 2018.
Dr. Loria is the founder of Dendrogenix SA, founded in 2018, and holds the title of Director.
Dr. Loria is currently the Chairman & President of Portable Genomics, Inc. Former positions include President & Chief Executive Officer at Epimmune, Inc. from 2001 to 2005, Principal at Sanofi, Principal at Novartis Corp., Principal at Biovector Therapeutics SA, and President at IDM Pharma, Inc. from 2001 to 2006.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-09-29 | 2,287,616 ( 10.09% ) | 12 M $ | 2026-05-30 |
Emile Loria active positions
| Companies | Position | Start |
|---|---|---|
Portable Genomics, Inc. | Chairman | - |
Dendrogenix SA
 Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer | Founder | 2017-12-31 |
Former positions of Emile Loria
| Companies | Position | End |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Founder | 2018-01-02 |
IDM Pharma, Inc.
 IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | President | 2006-01-08 |
Epimmune, Inc.
 Epimmune, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to treat and prevent infectious diseases and cancer | President | 2005-08-16 |
Ms Medical Synergy SA
 Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Founder | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
24
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Epimmune, Inc.
Epimmune, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to treat and prevent infectious diseases and cancer | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Biovector Therapeutics SA
 Biovector Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops products for prevention and treatment of infectious disease and cancer | Health Technology |
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Health Technology |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Ms Medical Synergy SA
Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Portable Genomics, Inc. | |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer | Health Technology |
- Stock Market
- Insiders
- Emile Loria
